Literature DB >> 21525341

Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.

Lingyun Li1, Bin Gu, Feng Zhou, Jing Chi, Fang Wang, Guangyong Peng, Fangyi Xie, Jian Qing, Dongju Feng, Shiqiang Lu, Kun Yao.   

Abstract

Human herpesvirus 6 (HHV-6) is an important immunosuppressive and immunomodulatory virus that primarily infects immune cells and strongly suppresses the proliferation of infected cells. However, the mechanisms responsible for the regulation and suppression mediated by HHV-6 are still unknown. In this study, we examined the ability of HHV-6A to manipulate cell cycle progression in infected cells and explored the potential molecular mechanisms. We demonstrated that infection with HHV-6A imposed a growth-inhibitory effect on HSB-2 cells by inducing cell cycle arrest at the G(2)/M phase. We then showed that the activity of the Cdc2-cyclin B1 complex was significantly decreased in HHV-6A-infected HSB-2 cells. Furthermore, we found that inactivation of Cdc2-cyclin B1 in HHV-6A-infected cells occurred through the inhibitory Tyr15 phosphorylation resulting from elevated Wee1 expression and inactivated Cdc25C. The reduction of Cdc2-cyclin B1 activity in HHV-6-infected cells was also partly due to the increased expression of the cell cycle-regulatory molecule p21 in a p53-dependent manner. In addition, HHV-6A infection activated the DNA damage checkpoint kinases Chk2 and Chk1. Our data suggest that HHV-6A infection induces G(2)/M arrest in infected T cells via various molecular regulatory mechanisms. These results further demonstrate the potential mechanisms involved in immune suppression and modulation mediated by HHV-6 infection, and they provide new insights relevant to the development of novel vaccines and immunotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525341      PMCID: PMC3126536          DOI: 10.1128/JVI.02577-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

Authors:  Akiko Yamane; Takehiko Mori; Shigeaki Suzuki; Ai Mihara; Rie Yamazaki; Yoshinobu Aisa; Tomonori Nakazato; Takayuki Shimizu; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

3.  Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection.

Authors:  Noriko Shirata; Ayumi Kudoh; Tohru Daikoku; Yasutoshi Tatsumi; Masatoshi Fujita; Tohru Kiyono; Yutaka Sugaya; Hiroki Isomura; Kanji Ishizaki; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

4.  Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity.

Authors:  Jennifer L Gardell; Paul Dazin; Janeen Islar; Til Menge; Claude P Genain; Patrice H Lalive
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

5.  Human herpesvirus 6B inhibits cell proliferation by a p53-independent pathway.

Authors:  Bodil Øster; Maja D Kaspersen; Emil Kofod-Olsen; Bettina Bundgaard; Per Höllsberg
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

6.  Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals.

Authors:  Fang Wang; Kun Yao; Quan-Zhang Yin; Feng Zhou; Chuan-Lin Ding; Guang-Yong Peng; Jian Xu; Yun Chen; Dong-Ju Feng; Chun-Lin Ma; Wen-Rong Xu
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

7.  Human herpesvirus 6A accelerates AIDS progression in macaques.

Authors:  Paolo Lusso; Richard W Crowley; Mauro S Malnati; Clelia Di Serio; Maurilio Ponzoni; Angelique Biancotto; Phillip D Markham; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

8.  Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication.

Authors:  Brian Dove; Gavin Brooks; Katrina Bicknell; Torsten Wurm; Julian A Hiscox
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.

Authors:  Clare E Davy; Deborah J Jackson; Kenneth Raj; Woei Ling Peh; Shirley A Southern; Papia Das; Rina Sorathia; Peter Laskey; Kate Middleton; Tomomi Nakahara; Qian Wang; Phillip J Masterson; Paul F Lambert; Scott Cuthill; Jonathan B A Millar; John Doorbar
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

10.  Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6.

Authors:  M-E Janelle; L Flamand
Journal:  Arch Virol       Date:  2006-02-13       Impact factor: 2.574

View more
  23 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

Review 2.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

Review 3.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

4.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 5.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

6.  Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.

Authors:  Fang Wang; Jing Chi; Guangyong Peng; Feng Zhou; Jinfeng Wang; Lingyun Li; Dongju Feng; Fangyi Xie; Bin Gu; Jian Qin; Yun Chen; Kun Yao
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

7.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

8.  Human herpesvirus 6A induces apoptosis of primary human fetal astrocytes via both caspase-dependent and -independent pathways.

Authors:  Bin Gu; Guo-Feng Zhang; Ling-Yun Li; Feng Zhou; Dong-Ju Feng; Chuan-Lin Ding; Jing Chi; Chun Zhang; Dan-Dan Guo; Jing-Feng Wang; Hong Zhou; Kun Yao; Wei-Xing Hu
Journal:  Virol J       Date:  2011-12-12       Impact factor: 4.099

9.  Human surfactant protein D alters oxidative stress and HMGA1 expression to induce p53 apoptotic pathway in eosinophil leukemic cell line.

Authors:  Lakshna Mahajan; Hrishikesh Pandit; Taruna Madan; Poonam Gautam; Ajit K Yadav; Himangi Warke; Curam S Sundaram; Ravi Sirdeshmukh; P Usha Sarma; Uday Kishore; Avadhesha Surolia
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.

Authors:  Junko Mori; Akiko Kawabata; Huamin Tang; Kenjiro Tadagaki; Hiroyuki Mizuguchi; Kazumichi Kuroda; Yasuko Mori
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.